We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Queen Alexandra Hospital Opens Fecal Bank

By HospiMedica International staff writers
Posted on 31 May 2016
Print article
Image: Clostridium difficile in a Petri dish (Photo courtesy of the University of Portsmouth).
Image: Clostridium difficile in a Petri dish (Photo courtesy of the University of Portsmouth).
Queen Alexandra Hospital (Portsmouth, United Kingdom) has opened a new frozen fecal bank, which could help cure for infections caused by Clostridium difficile.

The bank is part of a pilot project run by Robert Porter, MD, a consultant in microbiology and infection at Portsmouth Hospitals' NHS Trust (Portsmouth, United Kingdom). The bank will give patients across the United Kingdom access to screened frozen fecal material from a healthy donor in order to deliver healthy bacteria into the gut of a patient suffering from severe C. difficile infection.

The frozen samples, collected from pre-screened volunteers, can be stored for up to three months, and can be transported anywhere in the United Kingdom within hours, using overnight cold storage delivery; a single fecal transplant from the bank will cost about £85. The bank is funded by the Wessex Academic Health Science Network (Southhampton, United Kingdom), and supported by senior lecturer and researcher Carole Fogg, PhD, of the University of Portsmouth (Portsmouth, United Kingdom).

“Fecal transplants are extremely successful, and the impact on people's lives of such a simple treatment is difficult to overstate,” said Dr. Porter. “This is about something we all do every day potentially saving other people's lives. The pilot bank service also opens doors to new research, which we fully intend to take forward.”

Clostridium difficile is a bacterium that causes infection leading to diarrhea, and is most often related to antibiotic use during medical treatment. It is especially dangerous for patients with weakened immune systems such as the elderly and those with inflammatory bowel disease (IBD). Treatment includes antibiotics, probiotics, toxin-binding medications, active vaccination, and intravenous immunoglobon. About 20% of patients are resistant to these treatment and need a fecal microbiota transplant, which has a 96% cure rate.

Related Links:
Queen Alexandra Hospital
Portsmouth Hospitals' NHS Trust
Wessex Academic Health Science Network
University of Portsmouth
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
EEG System
BRAIN QUICK

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.